Search company, investor...

Nuclear Threat Initiative

Founded Year



Grant | Alive

About Nuclear Threat Initiative

Nuclear Threat Initiative aim to strengthen biosecurity, reduce biological risks posed by advances in technology, create new approaches to improve infectious disease surveillance, and identify and fill gaps to measurably strengthen global health security capabilities.

Headquarters Location

1776 Eye Street Suite 600

Washington, DC, 20006,

United States

Missing: Nuclear Threat Initiative's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Nuclear Threat Initiative's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Nuclear Threat Initiative News

US Behind Monkeypox Infection; Claim Based on Nuclear Threat Initiative Report Spreads on Chinese Social Media

May 23, 2022

All about Monkeypox as Massachusetts reports first case in the US Chinese influencers are spreading speculation that the US is behind the surging cases of the monkeypox infections worldwide. Shu Chang, a nationalist influencer in China, misinterpreted a report and stated that the US had a plan to leak bioengineered monkeypox virus. The influencer, who has 6.41 million Weibo followers, misjudged a 2021 report on biosecurity preparedness planning by a US non-government organization, Nuclear Threat Initiative, according to Bloomberg . Symptoms of MonkeypoxTwitter The World Health Organization confirmed 92 cases in 12 countries and doctors are also assessing that the disease could have a massive impact on the sexual health of the people. Shu Chang Miscalculated a Report Shu's post has gone popular on Weibo as over 7,500 users have liked the post and it received more than 700 comments. Her followers have agreed with her claims and many stated that the evilness of the US can't be imagined. People infected with the monkeypox develop symptoms similar to flu as fever, body aches, and chills but they also get also swollen lymph nodes and a distinctive rash on the face and other body parts. Symptoms of MonkeypoxTwitter Monkeypox is a Trending Issue in China Previously, China has claimed that the US -- in one of its military bases -- developed coronavirus, which was first found in the Chinese city of Wuhan where Beijing runs a virology institute. So far, China's state media has speculated that the US is behind monkeypox infections. But previously it endorsed Beijing's claim that Washington developed coronavirus in its military base. For the past three days, monkeypox has been a trending issue in China as the US has reported cases from three of its 50 states. As of Monday, a hashtag on the US monkeypox cases has received over 51 million views. Monkeypox can easily transmit from sneezes or coughs with a monkeypox rash. The disease is fatal but the current strain spreading globally is milder and has a fatality rate of one in 100. Read more

Nuclear Threat Initiative Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nuclear Threat Initiative Rank

Nuclear Threat Initiative Frequently Asked Questions (FAQ)

  • When was Nuclear Threat Initiative founded?

    Nuclear Threat Initiative was founded in 2001.

  • Where is Nuclear Threat Initiative's headquarters?

    Nuclear Threat Initiative's headquarters is located at 1776 Eye Street, Washington.

  • What is Nuclear Threat Initiative's latest funding round?

    Nuclear Threat Initiative's latest funding round is Grant.

  • Who are the investors of Nuclear Threat Initiative?

    Investors of Nuclear Threat Initiative include HDR Global Trading.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.